Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 35, Issue 11, Pages 1763-1774
Publisher
Springer Nature America, Inc
Online
2018-10-24
DOI
10.1007/s12325-018-0805-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
- (2018) Daniel C. Malone et al. VALUE IN HEALTH
- Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
- (2017) Thomas R. Frieden NEW ENGLAND JOURNAL OF MEDICINE
- Machine Learning and Prediction in Medicine — Beyond the Peak of Inflated Expectations
- (2017) Jonathan H. Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial
- (2016) Niteesh K. Choudhry et al. AMERICAN HEART JOURNAL
- Pragmatic Trials
- (2016) Harold C. Sox et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pragmatic Trials
- (2016) Ian Ford et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin
- (2015) N. Freemantle et al. DIABETES OBESITY & METABOLISM
- New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
- (2015) G. B. Bolli et al. DIABETES OBESITY & METABOLISM
- Propensity scores: Methods, considerations, and applications in the Journal of Thoracic and Cardiovascular Surgery
- (2015) Timothy L. McMurry et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Basing approval of drugs for type 2 diabetes on real world outcomes
- (2015) Andrew McGovern et al. BMJ-British Medical Journal
- Basing approval of drugs for type 2 diabetes on real world outcomes
- (2015) Andrew McGovern et al. BMJ-British Medical Journal
- Is the real-world evidence or hypothesis: a tale of two retrospective studies
- (2015) Robert W Dubois Journal of Comparative Effectiveness Research
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)
- (2014) Hannele Yki-Järvinen et al. DIABETES CARE
- Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study)
- (2014) P. R. Wermeling et al. DIABETES OBESITY & METABOLISM
- Real World Studies, Challenges, Needs and Trends from the Industry
- (2014) M. Batrouni et al. VALUE IN HEALTH
- Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
- (2013) D. M. Nathan et al. DIABETES CARE
- The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
- (2013) Syed S Mahmood et al. LANCET
- Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research
- (2013) N. Freemantle et al. BMJ-British Medical Journal
- Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview
- (2011) Su Golder et al. PLOS MEDICINE
- EBM, HTA, and CER: Clearing the Confusion
- (2010) BRYAN R. LUCE et al. MILBANK QUARTERLY
- Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATETMstudy
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- Explanatory and Pragmatic Attitudes in Therapeutical Trials
- (2009) Daniel Schwartz et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now